See more : Reunert Limited (RLO.JO) Income Statement Analysis – Financial Results
Complete financial analysis of DENTSPLY SIRONA Inc. (XRAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DENTSPLY SIRONA Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Paramount Bed Holdings Co., Ltd. (PBHDF) Income Statement Analysis – Financial Results
- Thai Enger Holding Public Company Limited (TIGER.BK) Income Statement Analysis – Financial Results
- Bajaj Auto Limited (BAJAJ-AUTO.NS) Income Statement Analysis – Financial Results
- tokentus investment AG (14D.DE) Income Statement Analysis – Financial Results
- Garware Marine Industries Limited (GARWAMAR.BO) Income Statement Analysis – Financial Results
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.97B | 3.92B | 4.25B | 3.34B | 4.03B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B | 2.93B | 2.54B | 2.22B | 2.16B | 2.19B | 2.01B | 1.81B | 1.72B | 1.69B | 1.57B | 1.51B | 1.13B | 889.80M | 830.90M | 795.10M | 720.80M | 656.60M | 572.00M | 524.80M | 552.60M | 84.60M | 54.50M | 29.40M | 18.60M | 16.20M | 12.70M | 10.30M |
| Cost of Revenue | 1.88B | 1.80B | 1.89B | 1.69B | 1.86B | 1.92B | 1.80B | 1.74B | 1.16B | 1.32B | 1.37B | 1.37B | 1.26B | 1.09B | 1.05B | 1.04B | 969.05M | 881.49M | 846.12M | 847.71M | 797.72M | 780.84M | 559.42M | 384.84M | 359.30M | 341.20M | 319.60M | 303.80M | 269.70M | 247.00M | 274.00M | 52.30M | 33.70M | 18.00M | 11.50M | 9.90M | 8.00M | 7.00M |
| Gross Profit | 2.09B | 2.13B | 2.36B | 1.66B | 2.17B | 2.07B | 2.19B | 2.00B | 1.52B | 1.60B | 1.58B | 1.56B | 1.27B | 1.13B | 1.11B | 1.15B | 1.04B | 929.01M | 869.02M | 846.52M | 773.20M | 732.90M | 569.67M | 504.95M | 471.60M | 453.90M | 401.20M | 352.80M | 302.30M | 277.80M | 278.60M | 32.30M | 20.80M | 11.40M | 7.10M | 6.30M | 4.70M | 3.30M |
| Gross Profit Ratio | 52.61% | 54.23% | 55.54% | 49.58% | 53.74% | 51.87% | 54.80% | 53.42% | 56.73% | 54.74% | 53.46% | 53.15% | 50.18% | 50.88% | 51.45% | 52.51% | 51.78% | 51.31% | 50.67% | 49.96% | 49.22% | 48.42% | 50.45% | 56.75% | 56.76% | 57.09% | 55.66% | 53.73% | 52.85% | 52.93% | 50.42% | 38.18% | 38.17% | 38.78% | 38.17% | 38.89% | 37.01% | 32.04% |
| Research & Development | 184.00M | 174.00M | 171.00M | 115.00M | 131.30M | 160.50M | 151.70M | 128.50M | 74.90M | 80.80M | 85.10M | 85.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.60B | 1.55B | 0.00 | 0.00 | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -7.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.62B | 1.59B | 1.55B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 160.30M | 180.00M | 16.70M | 10.50M | 5.50M | 3.90M | 3.40M | 2.90M | 2.30M |
| Other Expenses | 374.00M | 1.29B | 18.00M | 271.00M | 115.00M | 1.34B | 2.07B | 44.10M | 81.20M | 11.10M | 13.40M | -490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.43M | 0.00 | 0.00 | 0.00 | 0.00 | 5.07M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 4.20M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K |
| Operating Expenses | 2.18B | 1.76B | 1.72B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 680.54M | 602.98M | 563.34M | 544.26M | 501.52M | 479.13M | 391.31M | 341.09M | 322.00M | 312.60M | 268.70M | 233.30M | 201.60M | 180.30M | 199.80M | 19.70M | 12.90M | 6.70M | 4.40M | 3.90M | 3.30M | 2.70M |
| Cost & Expenses | 4.05B | 3.56B | 3.61B | 3.12B | 3.59B | 3.64B | 3.48B | 3.27B | 2.23B | 2.47B | 2.52B | 2.52B | 2.20B | 1.83B | 1.77B | 1.78B | 1.65B | 1.48B | 1.41B | 1.39B | 1.30B | 1.26B | 950.73M | 725.94M | 681.30M | 653.80M | 588.30M | 537.10M | 471.30M | 427.30M | 473.80M | 72.00M | 46.60M | 24.70M | 15.90M | 13.80M | 11.30M | 9.70M |
| Interest Income | 0.00 | 60.00M | 55.00M | 1.00M | 2.40M | 2.10M | 2.40M | 2.00M | 2.20M | 5.59M | 8.12M | 8.76M | 9.46M | 4.25M | 5.03M | 17.09M | 26.43M | 12.48M | 9.01M | 5.47M | 1.87M | 0.00 | 0.00 | 862.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.00M | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M | 38.30M | 35.90M | 55.90M | 46.91M | 49.63M | 56.85M | 44.62M | 25.09M | 17.83M | 32.53M | 11.98M | 10.80M | 17.77M | 25.10M | 26.08M | 38.18M | 0.00 | 10.15M | 8.50M | 157.10M | 8.10M | 6.00M | 12.20M | 0.00 | 39.20M | 3.80M | 2.80M | 800.00K | 0.00 | 200.00K | 400.00K | 400.00K |
| Depreciation & Amortization | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M | 316.40M | 271.70M | 122.90M | 129.08M | 127.90M | 129.20M | 85.04M | 66.34M | 65.18M | 56.93M | 50.29M | 47.43M | 50.56M | 49.30M | 45.66M | 43.86M | 54.33M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K | 400.00K |
| EBITDA | 232.00M | -677.00M | 972.00M | 336.00M | 706.60M | -585.30M | -1.25B | 770.50M | 579.30M | 575.25M | 544.88M | 513.34M | 378.71M | 440.00M | 437.28M | 444.33M | 432.26M | 373.21M | 139.00M | 348.77M | 317.34M | 297.63M | 232.70M | 205.22M | 189.20M | 178.70M | 164.90M | 147.60M | 122.20M | 117.50M | 98.60M | 31.60M | 15.60M | 10.30M | 5.90M | 3.20M | 2.90M | 1.80M |
| EBITDA Ratio | 5.85% | 16.17% | 23.57% | 23.64% | 20.97% | 49.83% | 65.43% | 20.63% | 18.87% | 16.01% | 15.11% | 14.80% | 13.26% | 18.11% | 17.97% | 22.19% | 20.92% | 21.14% | 33.94% | 21.25% | 19.96% | 20.02% | 18.64% | 23.38% | 22.41% | 31.40% | 22.56% | 22.08% | 21.64% | 21.95% | 18.24% | 18.79% | 18.72% | 20.07% | 16.67% | 17.90% | 14.17% | 9.71% |
| Operating Income | -85.00M | 306.00M | 622.00M | 456.00M | 522.30M | -958.10M | -1.59B | 454.70M | 375.20M | 445.60M | 419.17M | 381.94M | 300.73M | 380.27M | 381.19M | 380.42M | 354.89M | 314.79M | 72.92M | 295.13M | 267.98M | 256.50M | 178.36M | 163.86M | 149.60M | 141.30M | 132.50M | 119.50M | 100.70M | 97.50M | 78.80M | 12.60M | 7.90M | 4.70M | 2.70M | 2.40M | 1.40M | 600.00K |
| Operating Income Ratio | -2.14% | 7.80% | 14.63% | 13.64% | 12.96% | -24.03% | -39.70% | 12.14% | 14.03% | 15.25% | 14.21% | 13.04% | 11.85% | 17.12% | 17.65% | 17.34% | 17.66% | 17.39% | 4.25% | 17.42% | 17.06% | 16.94% | 15.80% | 18.42% | 18.00% | 17.77% | 18.38% | 18.20% | 17.60% | 18.58% | 14.26% | 14.89% | 14.50% | 15.99% | 14.52% | 14.81% | 11.02% | 5.83% |
| Total Other Income/Expenses | -90.00M | -118.00M | -63.00M | -57.00M | -7.60M | -400.00K | -41.20M | -13.80M | -45.50M | -41.23M | -49.87M | -51.26M | -44.62M | -22.62M | -17.83M | -24.95M | 3.24M | 43.00K | -234.64M | -20.98M | -16.79M | -35.52M | 6.76M | -12.06M | -11.50M | -86.10M | -10.40M | -8.60M | -10.60M | -5.90M | -23.00M | -2.30M | -3.50M | -2.90M | -800.00K | 300.00K | -200.00K | -300.00K |
| Income Before Tax | -175.00M | -1.06B | 559.00M | -60.00M | 345.40M | -958.40M | -1.63B | 440.90M | 329.70M | 404.37M | 369.34M | 330.68M | 256.11M | 357.66M | 363.36M | 355.47M | 358.14M | 314.84M | 71.04M | 274.16M | 251.20M | 220.99M | 185.13M | 151.80M | 138.10M | 55.10M | 122.10M | 110.90M | 90.10M | 91.60M | 55.80M | 9.10M | 5.00M | 3.90M | 2.70M | 2.20M | 1.10M | 0.00 |
| Income Before Tax Ratio | -4.41% | -26.90% | 13.15% | -1.80% | 8.57% | -24.04% | -40.73% | 11.77% | 12.33% | 13.84% | 12.52% | 11.29% | 10.09% | 16.10% | 16.82% | 16.20% | 17.82% | 17.39% | 4.14% | 16.18% | 15.99% | 14.60% | 16.40% | 17.06% | 16.62% | 6.93% | 16.94% | 16.89% | 15.75% | 17.45% | 10.10% | 10.76% | 9.17% | 13.27% | 14.52% | 13.58% | 8.66% | 0.00% |
| Income Tax Expense | -43.00M | -105.00M | 138.00M | 23.00M | 82.30M | 52.50M | -53.20M | 9.50M | 77.00M | 81.12M | 52.15M | 8.92M | -11.02M | 89.23M | 88.94M | 71.60M | 98.48M | 91.12M | 25.63M | 63.87M | 81.34M | 73.03M | 63.63M | 50.78M | 48.20M | 20.30M | 47.50M | 43.70M | 36.10M | 37.50M | 27.70M | 3.80M | 2.10M | 1.50M | 1.00M | 900.00K | 300.00K | 500.00K |
| Net Income | -132.00M | -950.00M | 411.00M | -83.00M | 262.90M | -1.01B | -1.57B | 429.90M | 251.20M | 322.85M | 313.19M | 314.21M | 244.52M | 265.71M | 274.26M | 283.87M | 259.65M | 223.72M | 45.41M | 253.17M | 174.18M | 147.95M | 121.50M | 101.02M | 89.90M | 34.80M | 74.60M | 67.20M | 54.00M | 62.00M | 14.10M | 5.30M | 2.90M | 2.40M | 1.70M | 1.30M | 800.00K | 100.00K |
| Net Income Ratio | -3.33% | -24.22% | 9.67% | -2.48% | 6.52% | -25.36% | -39.39% | 11.48% | 9.39% | 11.05% | 10.61% | 10.73% | 9.64% | 11.96% | 12.70% | 12.94% | 12.92% | 12.36% | 2.65% | 14.94% | 11.09% | 9.77% | 10.76% | 11.35% | 10.82% | 4.38% | 10.35% | 10.23% | 9.44% | 11.81% | 2.55% | 6.26% | 5.32% | 8.16% | 9.14% | 8.02% | 6.30% | 0.97% |
| EPS | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 | 1.90 | 1.71 | 1.44 | 0.29 | 1.58 | 1.11 | 0.95 | 0.78 | 0.65 | 0.57 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| EPS Diluted | -0.62 | -4.41 | 1.87 | -0.38 | 1.17 | -4.51 | -6.86 | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 | 1.87 | 1.68 | 1.41 | 0.28 | 1.55 | 1.09 | 0.93 | 0.77 | 0.65 | 0.56 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| Weighted Avg Shares Out | 212.00M | 215.50M | 218.40M | 219.20M | 223.10M | 224.17M | 229.29M | 218.00M | 140.00M | 141.70M | 142.70M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M | 155.23M | 159.19M | 160.77M | 157.65M | 156.36M | 155.34M | 155.57M | 158.26M | 159.99M | 161.81M | 161.52M | 162.07M | 165.99M | 151.00M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
| Weighted Avg Shares Out (Dil) | 212.00M | 215.50M | 220.20M | 219.20M | 224.40M | 224.30M | 229.40M | 221.60M | 142.50M | 144.20M | 145.00M | 143.95M | 143.55M | 145.99M | 150.10M | 151.68M | 154.72M | 158.27M | 162.02M | 164.03M | 161.29M | 159.99M | 157.95M | 157.12M | 158.73M | 160.79M | 162.69M | 161.52M | 162.19M | 165.99M | 156.59M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
DENTSPLY SIRONA Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Assist The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for violations of §§10(b)...
Lost Money on Dentsply Sirona Inc.(XRAY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY)...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Dentsply Sirona Inc. Lawsuit - XRAY
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
XRAY Class Action Alert: Robbins LLP Reminds Dentsply Sirona Inc. Investors of the Lead Plaintiff Deadline in the XRAY Securities Class Action
SAN DIEGO, CA / ACCESSWIRE / December 5, 2024 / Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. (NASDAQ:XRAY) common stock between December 1, 2022 and November...
January 27, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against XRAY
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected]...
Levi & Korsinsky Reminds Dentsply Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 – XRAY
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit.
XRAY LAWSUIT ALERT: Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
XRAY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY)...
Source: https://incomestatements.info
Category: Stock Reports